Keywords
Rheumatology ×
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

206 Search results.

Eligibility Polyarticular-course Juvenile Idiopathic Arthritis (JIA) NCT01550003

- 1/22/21 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Pediatric Arthritis Study of Certolizumab Pegol; ODM derived from: https://clinicaltrials.gov/show/NCT01550003

Eligibility Rheumatoid Arthritis NCT01197534

- 1/22/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.; ODM derived from: https://clinicaltrials.gov/show/NCT01197534

Eligibility Rheumatoid Arthritis NCT02507752

- 11/24/20 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab; ODM derived from: https://clinicaltrials.gov/show/NCT02507752

Eligibility Effect Assessment Of Periodontal Prophylaxis On Patients With Anti-CCP Positive Early Rheumatoid Arthritis NCT01706874 - Eligibility Patients With Anti-CCP Positive Early Rheumatoid Arthritis NCT01706874

- 11/18/20 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect Assessment of Periodontal Prophylaxis on Rheumatoid Arthritis Activity.; ODM derived from: https://clinicaltrials.gov/show/NCT01706874

Eligibility Juvenile Idiopathic Arthritis NCT02218580

- 4/30/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Massage Therapy in Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02218580

Eligibility Juvenile Idiopathic Arthritis NCT02165345

- 4/30/20 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Extension Study Evaluating the Safety and Efficacy of Subcutaneous RoActemra/Actemra Administration in Patients With Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02165345

Eligibility Juvenile Idiopathic Arthritis NCT01727986

- 4/29/20 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study; ODM derived from: https://clinicaltrials.gov/show/NCT01727986

Eligibility Juvenile Idiopathic Arthritis NCT01673919

- 4/29/20 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study; ODM derived from: https://clinicaltrials.gov/show/NCT01673919

Eligibility Juvenile Idiopathic Arthritis NCT01557452

- 4/29/20 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis (JIA); ODM derived from: https://clinicaltrials.gov/show/NCT01557452

Eligibility Juvenile Idiopathic Arthritis NCT01667471

- 4/29/20 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study; ODM derived from: https://clinicaltrials.gov/show/NCT01667471

Eligibility Juvenile Idiopathic Arthritis NCT01434082

- 4/29/20 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01434082

Eligibility Juvenile Idiopathic Arthritis NCT01230827

- 4/28/20 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS); ODM derived from: https://clinicaltrials.gov/show/NCT01230827